NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
0.7120
+0.0410 (6.11%)
At close: Dec 5, 2025, 4:00 PM EST
0.7119
-0.0001 (-0.01%)
After-hours: Dec 5, 2025, 6:20 PM EST

Company Description

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States.

The company also provides solutions for spinal cord stimulation, radio frequency and brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders.

The company also focuses on applications of its technology associated with artificial intelligence. It has partnership with RBC Medical Innovations to develop a radio frequency ablation generator.

NeuroOne Medical Technologies Corporation is based in Eden Prairie, Minnesota.

NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies logo
Country United States
Founded 2009
Industry Medical Devices
Sector Healthcare
Employees 17
CEO David Rosa

Contact Details

Address:
7599 Anagram Drive
Eden Prairie, Minnesota 55344
United States
Phone 952 426 1383
Website nmtc1.com

Stock Details

Ticker Symbol NMTC
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year October - September
Reporting Currency USD
CIK Code 0001500198
CUSIP Number 64130M209
ISIN Number US64130M2098
Employer ID 27-0863354
SIC Code 3841

Key Executives

Name Position
David A. Rosa M.D. President, Chief Executive Officer and Director
Ronald W. McClurg Chief Financial Officer
Christopher R. Volker CFA Chief Operating Officer
Mark Christianson Co-Founder, Business Development Director and Medical Sales Liaison
Steven Mertens Chief Technology Officer
Emily Johns Chief Administrative Officer and General Counsel
Hijaz Haris Vice President of Marketing
Dr. Parag G. Patil M.D., Ph.D. Chief Medical Advisor

Latest SEC Filings

Date Type Title
Nov 12, 2025 SCHEDULE 13G/A Filing
Nov 5, 2025 8-K Current Report
Oct 6, 2025 8-K Current Report
Aug 20, 2025 144 Filing
Aug 18, 2025 8-K Current Report
Aug 15, 2025 8-K Current Report
Aug 15, 2025 424B5 Filing
Aug 14, 2025 SCHEDULE 13G Filing
Aug 14, 2025 10-Q Quarterly Report
Aug 14, 2025 8-K Current Report